摘要
过去的几十年,在急性心肌梗死的诊断、治疗及预后方面获得了巨大的进步,其中生物标志物在急性心肌梗死患者的术后管理中发挥重要的作用。现综述近十年的报道,聚焦于预后相关生物标志物对急性心肌梗死患者经皮冠状动脉介入术治疗后,短、长期风险评估的研究进展。
In the past few decades, the diagnosis, treatment and prognosis of acute myocardial infarction （AMI） have improved dra- matically. Biomarkers play important roles in the management of AMI patients after treatment. In this review, we focus on advances of prog- nostic biomarkers in the past decade for short- and long-term risk assessment in patients with AMI after percutaneous coronary intervention.
出处
《心血管病学进展》
CAS
2016年第1期37-41,共5页
Advances in Cardiovascular Diseases
基金
上海医学重点专科建设计划(ZK2012A39)
关键词
生物标志物
急性心肌梗死
经皮冠状动脉介入术
预后
Biomarkers
Acute myocardial infarction
Percutaneous coronary intervention
Prognosis
